EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Systematic Comparison of the TGF-β Isoforms in Normal Dermal and Lung Fibroblasts Identifies TGF-β2 and TGF-β3 as Priority Targets in Tissue Fibrosis

Raveen Badyal iD, Brandon Kohlen iD, Kevin J Keen iD, James V Dunne, Tillie-Louise Hackett iD

Cells · 10.04.2026 · 15 (8) · 671

DOI: 10.3390/cells15080671 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cells, online erschienen am 10.04.2026. Verfasst von Raveen Badyal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada. Hauptthemen laut MEDLINE: Fibroblasts, Lung, Transforming Growth Factor beta3, Transforming Growth Factor beta2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canada Research Chairs, Scleroderma Association of British Columbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is a multi-organ autoimmune disease characterized by fibrosis of the skin and internal organs. Interstitial lung disease (ILD) is a major complication and leading cause of mortality in SSc. Transforming growth factor-β (TGF-β) has been implicated as a central mediator of fibrosis; however, while TGF-β1 has been extensively studied, the roles of TGF-β2 and TGF-β3 remain incompletely defined. Here, we systematically compared the effects of TGF-β1, TGF-β2, and TGF-β3 in dermal and lung fibroblasts, evaluating extracellular matrix synthesis and contraction, cytokine secretion, proliferation, and myofibroblast differentiation. TGF-β2 and TGF-β3 induced greater profibrotic cytokine release of Interleukin (IL)-6 and IL-11 and increased collagen-I and fibronectin synthesis compared with TGF-β1 in dermal and lung fibroblasts (all p < 0.05). TGF-β2 and TGF-β3 stimulated greater collagen-I contraction in dermal fibroblasts (p < 0.05), but greater myofibroblast differentiation in lung fibroblasts (p < 0.05). The TGF-β isoforms did not affect proliferation. All TGF-β isoforms activated SMAD2/3 signalling; however, TGF-β2 and TGF-β3 reduced expression of TGF-β Receptor II and the inhibitory regulator, SMAD7. In summary, TGF-β2 and TGF-β3 have a more pronounced profibrotic effect than TGF-β1 on dermal and lung fibroblast functions, making them potential targets for treatment for skin and lung fibrosis in diseases such as SSc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsLungTransforming Growth Factor beta3Transforming Growth Factor beta2DermisSkinHumansFibrosisProtein IsoformsCell DifferentiationCell ProliferationMyofibroblastsSignal TransductionExtracellular Matrix

Stichwörter der Autor:innen

collagen gel modeldermal fibroblastsextracellular matrix productionfibrosisinflammationlung fibroblastsmyofibroblast differentiationproliferationtransforming growth factor-beta isoforms

Substanzen

Transforming Growth Factor beta3Protein IsoformsTransforming Growth Factor beta2

Autor:innen und Institutionen

  • Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada.
  • Department of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Department of Mathematics and Statistics, The University of Northern British Columbia, Prince George, BC V2N 4Z9, Canada.
  • Department of Medicine, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

ORCID-Profile: Raveen Badyal, Brandon Kohlen, Kevin J Keen, Tillie-Louise Hackett

Förderung

  • CIHR
  • Canada Research Chairs
  • Scleroderma Association of British Columbia
  • Canadian Institutes of Health Research
  • Canada Graduate Scholarships—Master’s programme award
  • Canada Graduate Scholarships—Doctoral programme award

Zitieren

APA

Badyal, R., Kohlen, B., Keen, K. J., Dunne, J. V., & Hackett, T. L. (2026). Systematic Comparison of the TGF-β Isoforms in Normal Dermal and Lung Fibroblasts Identifies TGF-β2 and TGF-β3 as Priority Targets in Tissue Fibrosis. Cells, 15(8), 671. https://doi.org/10.3390/cells15080671

Vancouver

Badyal R, Kohlen B, Keen KJ, Dunne JV, Hackett TL. Systematic Comparison of the TGF-β Isoforms in Normal Dermal and Lung Fibroblasts Identifies TGF-β2 and TGF-β3 as Priority Targets in Tissue Fibrosis. Cells. 2026;15(8):671. doi:10.3390/cells15080671

BibTeX
@article{Badyal2026,
  author = {Badyal, Raveen and Kohlen, Brandon and Keen, Kevin J and Dunne, James V and Hackett, Tillie-Louise},
  title = {Systematic Comparison of the TGF-β Isoforms in Normal Dermal and Lung Fibroblasts Identifies TGF-β2 and TGF-β3 as Priority Targets in Tissue Fibrosis},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {671},
  doi = {10.3390/cells15080671}
}
Kostenlos starten →